INtensity of OVarian Stimualtion and Euploid Embryos
ConditionFertility
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age38-42
SponsorFundación Santiago Dexeus Font
About this trial
This randomized trial was designed as a no-inferiority trial aiming to evaluate if the intensity of stimulation (a milder vs a more intense approach) may have an impact on the number of euploid embryos and the morpho kinetic parameters in advanced age women undergoing PGT-A with a PPOS protocol.
Eligibility criteria
Qualifiers
Infertile patients with indication for IVF
Undergoing preimplantation genetic screening cycles
AMH >= 1.5 ng/ml and < 3.5 ng/ml (AMH result of up to one year will be valid)
BMI 18.5 - 30 Kg/m2
Disqualifiers
Severe male factor requiring TESE (testicular sperm extraction)
AMH < 1.5 ng/ml or >= 3.5 ng/ml
Administration of any other drug potentially interfering with the treatment
Contraindication for hormonal treatment
Trial design
Treatments tested in this trial
- Follitropin-delta (Rekovelle) 20 mcg/day from D1
- Follitropin-delta (Rekovelle) 15 mcg/day from D1
Treatment groups
110 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov